"Thrombolytic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
Descriptor ID |
D015912
|
MeSH Number(s) |
E02.319.913
|
Concept/Terms |
Thrombolytic Therapy- Thrombolytic Therapy
- Therapeutic Thrombolysis
- Therapeutic Thrombolyses
- Thrombolyses, Therapeutic
- Thrombolysis, Therapeutic
- Therapy, Fibrinolytic
- Fibrinolytic Therapies
- Therapies, Fibrinolytic
- Therapy, Thrombolytic
- Therapies, Thrombolytic
- Thrombolytic Therapies
- Fibrinolytic Therapy
|
Below are MeSH descriptors whose meaning is more general than "Thrombolytic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Thrombolytic Therapy".
This graph shows the total number of publications written about "Thrombolytic Therapy" by people in this website by year, and whether "Thrombolytic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 5 | 0 | 5 |
1996 | 2 | 2 | 4 |
1997 | 1 | 3 | 4 |
1998 | 3 | 0 | 3 |
1999 | 3 | 3 | 6 |
2000 | 6 | 4 | 10 |
2001 | 8 | 3 | 11 |
2002 | 1 | 1 | 2 |
2003 | 5 | 2 | 7 |
2004 | 9 | 3 | 12 |
2005 | 6 | 3 | 9 |
2006 | 4 | 0 | 4 |
2007 | 7 | 1 | 8 |
2008 | 4 | 3 | 7 |
2009 | 2 | 1 | 3 |
2010 | 2 | 3 | 5 |
2011 | 4 | 4 | 8 |
2012 | 2 | 0 | 2 |
2013 | 9 | 1 | 10 |
2014 | 2 | 1 | 3 |
2015 | 5 | 3 | 8 |
2016 | 9 | 0 | 9 |
2017 | 2 | 1 | 3 |
2018 | 3 | 2 | 5 |
2019 | 8 | 3 | 11 |
2020 | 7 | 4 | 11 |
2021 | 5 | 1 | 6 |
2022 | 0 | 4 | 4 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombolytic Therapy" by people in Profiles.
-
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Ann Neurol. 2024 Feb; 95(2):347-361.
-
COVID-19 and Blood Clots: A Report of Massive Pulmonary Embolism in COVID-19 Patient Supported on Veno-Venous ECMO and the Utility of Thrombolysis. J Extra Corpor Technol. 2022 Sep; 54(3):235-238.
-
Thrombolysis Experience in Costa Rica Compared Against Individual Patient Data from two Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2022 Aug; 31(8):106599.
-
Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion. Pediatr Radiol. 2022 11; 52(12):2413-2420.
-
Impact of Telestroke Implementation on Emergency Department Transfer Rate. Neurology. 2022 04 19; 98(16):e1617-e1625.
-
Fibrinolytic Therapy in Patients with Acute ST-elevation Myocardial Infarction. Interv Cardiol Clin. 2021 07; 10(3):381-390.
-
Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19. J Am Coll Surg. 2021 06; 232(6):1021-1022.
-
Decade-Long Nationwide Trends and Disparities in Use of Comfort Care Interventions for Patients With Ischemic Stroke. J Am Heart Assoc. 2021 04 20; 10(8):e019785.
-
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis. Pediatr Hematol Oncol. 2021 Sep; 38(6):528-542.
-
Blood pressure excursions in acute ischemic stroke patients treated with intravenous thrombolysis. J Hypertens. 2021 02 01; 39(2):266-272.